Sonoma Pharmaceuticals (SNOA) FCF Margin Growth (3y) (2013 - 2026)
Sonoma Pharmaceuticals (SNOA) FCF Margin Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 253.00 |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | -1,444.00 |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -990.00 |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | -2,377.00 |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | -1,484.00 |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 4,765.00 |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 1,067.00 |
| 10 | Sonoma Pharmaceuticals | 179.80 | -2.40 Mn | 2.18 Mn | 7,744.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 7,744.00 |
| Dec 31, 2025 | -577.00 |
| Sep 30, 2025 | 4,418.00 |
| Jun 30, 2025 | -1,376.00 |
| Mar 31, 2025 | 5,962.00 |
| Dec 31, 2024 | 2,706.00 |
| Sep 30, 2024 | 4,466.00 |
| Jun 30, 2024 | 749.00 |
| Mar 31, 2024 | 7,360.00 |
| Dec 31, 2023 | -4,877.00 |
| Sep 30, 2023 | -3,818.00 |
| Jun 30, 2023 | 3,386.00 |
| Mar 31, 2023 | 967.00 |
| Dec 31, 2022 | 333.00 |
| Sep 30, 2022 | -4,236.00 |
| Jun 30, 2022 | -5,522.00 |
| Mar 31, 2022 | -42.00 |
| Dec 31, 2021 | 3,405.00 |
| Sep 30, 2021 | 3,693.00 |
| Jun 30, 2021 | 3,613.00 |